Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Otis W. Brawley"'
Autor:
James L. Zazzali, Jennie H. Best, Shalini V. Mohan, Otis W. Brawley, John S Pauk, John M. Pagel, Boris Ivanov, Krish Patel, Krutika Jariwala-Parikh, Amanda M. Kong
Publikováno v:
Advances in Therapy
Introduction Coronavirus disease 2019 (COVID-19) can present as a range of symptoms, from mild to critical; lower pulmonary involvement, including pneumonia, is often associated with severe and critical cases. Understanding the baseline characteristi
Autor:
Ahmedin Jemal, Otis W. Brawley, Stacey A. Fedewa, Kevin J. Cullen, J. Leonard Lichtenfeld, Farhad Islami, Richard C. Wender, Jiemin Ma
Publikováno v:
CA: A Cancer Journal for Clinicians. 69:351-362
A summary evaluation of the 2015 American Cancer Society (ACS) challenge goal showed that overall US mortality from all cancers combined declined 26% over the period from 1990 to 2015. Recent research suggests that US cancer mortality can still be lo
Autor:
Lauren R. Teras, Eric J. Jacobs, Otis W. Brawley, Jeffrey Drope, Clifford E Douglas, Alpa V. Patel, Richard C. Wender, Susan M. Gapstur, Marjorie L. McCullough
Publikováno v:
CA: A Cancer Journal for Clinicians. 68:446-470
In the United States, it is estimated that more than 1.7 million people will be diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial costs associated with cancer risk factors and cancer care are enormous. To sub
Autor:
Christopher S. Lathan, John M. Carethers, Jennifer J. Griggs, Otis W. Brawley, Scarlett Lin Gomez, Nina A. Bickell, J. Leonard Lichtenfeld, Margaret Foti, Blase N. Polite, Lucile L. Adams-Campbell, Christopher R. Flowers, Worta McCaskill-Stevens, Electra D. Paskett, Christopher I. Li
Publikováno v:
Journal of Clinical Oncology. 35:3075-3082
The academic field of cancer health disparities was stimulated by the U.S. civil rights movement. Concerns about civil rights led to concerns about equality in health care. The first publications to make the observation that black Americans have high
Publikováno v:
American Society of Clinical Oncology Educational Book. :e80-e87
Results of a number of studies demonstrate that the serum prostate-specific antigen (PSA) in and of itself is an inadequate screening test. Today, one of the most pressing questions in prostate cancer medicine is how can screening be honed to identif
Autor:
Farhad, Islami, Ann, Goding Sauer, Kimberly D, Miller, Rebecca L, Siegel, Stacey A, Fedewa, Eric J, Jacobs, Marjorie L, McCullough, Alpa V, Patel, Jiemin, Ma, Isabelle, Soerjomataram, W Dana, Flanders, Otis W, Brawley, Susan M, Gapstur, Ahmedin, Jemal
Publikováno v:
CA: a cancer journal for clinicians. 68(1)
Contemporary information on the fraction of cancers that potentially could be prevented is useful for priority setting in cancer prevention and control. Herein, the authors estimate the proportion and number of invasive cancer cases and deaths, overa
Autor:
Tim, Byers, Richard C, Wender, Ahmedin, Jemal, Arnold M, Baskies, Elizabeth E, Ward, Otis W, Brawley
Publikováno v:
CA: a cancer journal for clinicians. 66(5)
In 1996, the Board of Directors of the American Cancer Society (ACS) challenged the United States to reduce what looked to be possible peak cancer mortality in 1990 by 50% by the year 2015. This analysis examines the trends in cancer mortality across
Autor:
Otis W Brawley, H. Gilbert Welch
Publikováno v:
Annals of Internal Medicine. 169:134
Cancer screening is often recommended to patients believed to have a specific risk factor, such as prostate cancer screening for men who have a family history of the disease or melanoma screening f...
Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer
Publikováno v:
Gastroenterology. 154:906-915.e7
BACKGROUND & AIMS: Previous studies reported that black vs white disparities in survival among elderly patients with colorectal cancer (CRC) were due to differences in tumor characteristics (tumor stage, grade, nodal status, and comorbidity) rather t
Autor:
Elaine W. Flagg, Mary Jo Lund, Brian Leyland-Jones, J. William Eley, Katrina F. Trivers, Otis W. Brawley, Sheryl G. A. Gabram, Peggy L. Porter, Ralph J. Coates, Ruth O'Regan
Publikováno v:
Breast Cancer Research and Treatment. 113:357-370
Background Breast cancers with a triple negative tumor (TNT) subtype (as defined by lacking protein expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)) preclude the use of available t